Siga nabs $10.7M from the US government in deal for its monkeypox antiviral

Siga nabs $10.7M from the US government in deal for its monkeypox antiviral

Source: 
Endpoints
snippet: 

The US government is all set to buy $10.7 million worth of Siga Technologies’ monkeypox oral antiviral, the company announced Thursday.

Of the total doses, $5.1 million worth of oral antivirals called Tpoxx (tecovirimat) will be delivered this year, with the US Department of Defense having the option of buying the rest at a later point.